sara m. tolaney, md, mph, on whether the results of the tailorx study are “practice changing”
Published 6 years ago • 39 plays • Length 0:16
Download video MP4
Download video MP3
Similar videos
-
1:48
sara m. tolaney, md, mph discusses the tailorx study
-
1:54
sara m. tolaney, md, mph, shares outcomes from the monaleesa-7 trial
-
1:55
sara m. tolaney, md, mph, shares outcomes from the impassion130 study in tnbc
-
2:02
sara m. tolaney, md, mph, on the efficacy & safety of combination eribulin pembrolizumab
-
1:58
sara m. tolaney, md, mph on whether cdk4/6 inhibitors can be used interchangeably
-
10:39
tsra #1minctconsult pulmonary nodules
-
20:24
disruption of cell division within anaphase by tumor treating fields
-
8:44
dr richard de boer discusses the tailorx trial of oncotypedx
-
1:10
sara m. tolaney, md, mph tells us about the outcomes of the monarch 2 study
-
1:49
sabcs22: sara tolaney, md, mph | dana-farber cancer institute
-
1:45
asco23: sara tolaney, md, mph | dana-farber cancer institute
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:38
sara m. tolaney, md, mph, discusses the fulvestrant ribociclib arm of the monaleesa-3 study
-
0:37
julie gralow, md, comments on the practice-changing implications of the tailorx study
-
13:10
expert perspectives in the management of triple-negative breast cancer with sara tolaney, md, mph
-
2:00
dr sara m. tolaney: challenges with treating, role of clinical trials in her2-positive breast cancer
-
1:32
dr tolaney on data with checkpoint inhibitor combinations in metastatic tnbc
-
1:20
dr tolaney on ongoing clinical trials in early-stage her2 breast cancer
-
3:13
sara tolaney md, mph shares results from the phase 2 atempt trial at sabcs 2019
-
1:44
dr. tolaney on the atempt trial for her2 breast cancer
-
1:47
an overview of the ma17r trial in breast cancer
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
Clip.africa.com - Privacy-policy